Targeting to lymphoid cells of the immune network.
D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D000954:Antigens, Surface / Q000276:immunology; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D000939:Epitopes; D006086:Graft vs Host Disease / Q000628:therapy; D006801:Humans; D007109:Immunity; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000628:therapy; D008214:Lymphocytes / Q000276:immunology*; D008215:Lymphocytes, Null / Q000276:immunology; D008223:Lymphoma / Q000628:therapy; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D000961:Antilymphocyte Serum; D000939:Epitopes